Abstract Submission is Closed
There is an opportunity to present your work in a two (2) to five (5) minute oral presentation in the fast-paced Ignite sessions if your abstract is accepted. Select poster or oral as your presentation preference for consideration during the abstract submission process.
Travel awardees are selected by the Biothreats Program Committee on the basis of the scientific quality of the submitted abstracts. Funding from this award is meant only to defray costs for the meeting; abstract submitters may need to obtain additional funding from other sources.
Additional Submission Information
All abstracts submitted for consideration will be reviewed by at least one member of the Program Committee. The committee will determine if the abstract merits inclusion in the program and, if accepted, will schedule the abstract in the appropriate session for the meeting. An abstract may be rejected for one or more of the following reasons. All decisions relating to acceptance or rejection are final.
- No Background or Hypothesis - The abstract does not clearly indicate the reason for conducting the research or the question being tested by the experiments performed.
- Inadequate Experimental Methods - The investigators failed to describe procedures used or neglected to include important or essential controls.
- Insufficient Data Presented - The investigators failed to show the outcome(s) of their research. Insufficient data are presented to support the authors' conclusion(s).
- No Summary Form of Essential Results - The investigators failed to concisely summarize the result(s) of their research.
- No Conclusion - The investigators failed to describe the conclusions of their research with regard to the hypothesis being tested.
- Duplicate Abstract - The abstract contents substantively overlap with contents of another submitted abstract by the same author or co-author. Reviewers may elect to accept a single abstract and suggest that the authors consolidate their material.
- Not appropriate for the Biothreats meeting - The content of the abstract is not relevant to the defined goals of the Biothreats meeting.
- Promotional in Nature - The abstract was written to promote a specific product or procedure on behalf of a specific company or organization.
- Poorly Written - Improper use of the English language renders the abstract incomprehensible.
- Duplicate Presenting Author - An author can be the presenting author on only one abstract.
Abstract disposition notices will be made available via email notification to presenting authors only the week of Nov. 18, 2019. It is the responsibility of the presenting author to inform all co-authors of disposition status and accepted abstract scheduling information. If you have not received notification by Nov. 21, 2019, please email email@example.com to have a disposition notice resent.
Withdrawals and Penalties
If an abstract must be withdrawn, the author must send a letter of explanation to ASM at firstname.lastname@example.org. If an accepted abstract is published prior to 2020 ASM Biothreats the authors agree to withdraw the abstract. Withdrawals of abstracts made after Dec. 1, 2019, can be subject to a penalty as described below.
Persons who submit abstracts should consider them official communication to the conference. The following cases can incur a penalty, prohibiting the author from presenting papers at ASM meetings and conferences for up to three years. A letter will be mailed to individuals being subject to this penalty. Those who wish to dispute the penalty must write a letter to the Biothreats Program Committee and send it to the attention of the Biothreats Program Assistant at email@example.com. A response letter will be sent to the presenting author once the committee has considered and acted on your exception request.
Please be advised that it is ASM’s policy that, while presenters are allowed to communicate with the press, their discussions may not be published until after the day and time of the actual presentation. Similarly, details of an invited presentation may not be part of an industry-sponsored symposium or other scientific event, unless scheduled after the day and time of the official ASM Biothreats Symposium presentation. Policy is in effect until January 30, 2020.